Brugarolas, from the Simmons Comprehensive Cancer Center at the University of Texas Southwestern Medical Center, in Dallas, USA, is interested in kidney cancer and renal cell carcinoma (RCC). He focuses on the molecular genetics and genomics of cancer, on molecularly targeted therapies, and the signalling mechanisms and mechanisms of resistance to targeted agents. He has been invited by Juan Valcárcel (CRG).